Paraneoplastic SIADH — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Treat the malignancy and begin fluid restriction with close sodium monitoring
The best answer is “Treat the malignancy and begin fluid restriction with close sodium monitoring”. The findings support SIADH. In chronic or minimally symptomatic disease, management begins with treating the cause, restricting fluid and reviewing medicines; additional urea, salt-loop or vasopressin-antagonist strategies are specialist decisions. Hypertonic saline is reserved for severe neurological symptoms, and overcorrection risks osmotic demyelination.
Reference: Kidney Health Australia: CKD Management in Primary Care, 5th edition: https://kidney.org.au/health-professionals/ckd-management-handbook/